DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Estraderm (Estradiol Transdermal) - Published Studies

 
 



Estraderm Related Published Studies

Well-designed clinical trials related to Estraderm (Estradiol Transdermal)

Pharmacokinetics of testosterone and estradiol gel preparations in healthy young men. [2013]

Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial. [2011.11.29]

Naproxen or estradiol for bleeding and spotting with the levonorgestrel intrauterine system: a randomized controlled trial. [2011.09.24]

Prevention of menstrual migraine with perimenstrual transdermal 17-beta-estradiol: a randomized, placebo-controlled, double-blind crossover study. [2011.08]

Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition. [2011.07]

[Influence of estradiol administration mode on plasma insulin-like growth factor-I (IGF-I) and its binding proteins 1 and 3 concentration in postmenopausal women treated with norethisterone acetate]. [2011.03]

Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial. [2011]

Clinical usefulness of a low-dose maintenance therapy with transdermal estradiol gel in Japanese women with estrogen deficiency symptoms. [2011]

Transdermal estradiol and oral or vaginal natural progesterone: bleeding patterns. [2010.10]

Effects of transdermal estradiol gel and oral tibolone on health-related quality of life after surgical menopause. [2010.09]

Gabapentin vs. low-dose transdermal estradiol for treating post-menopausal women with moderate to very severe hot flushes. [2010.05]

Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp. [2010.01]

Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp. [2010]

Effects of variations in serum estradiol concentrations on secretory endometrial development and function in experimentally induced cycles in normal women. [2009.12]

Micro-dose transdermal estradiol for relief of hot flushes in postmenopausal Asian women: a randomized controlled trial. [2009.10]

Steady-state pharmacokinetics following application of a novel transdermal estradiol spray in healthy postmenopausal women. [2009.09]

Low-dose transdermal estradiol induces breast density and heterogeneity changes comparable to those of raloxifene. [2009.07]

[Effects and safety of gonadotrophin-releasing hormone agonist combined with estradiol patch and oral medroxyprogesterone acetate on endometriosis] [2009.07]

Micro-dose transdermal estradiol for relief of hot flushes in postmenopausal Asian women: a randomized controlled trial. [2009.05.25]

Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trial. [2009.05]

Effect of raloxifene and low-dose percutaneous 17beta-estradiol on menopause symptoms and endometrium-A randomized controlled trial. [2009.01.20]

Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women. [2009.01]

Effects of either tibolone or continuous combined transdermal estradiol with medroxyprogesterone acetate on coagulatory factors and lipoprotein(a) in menopause. [2009]

Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial. [2008.12]

Metabolic syndrome in postmenopausal women: the influence of oral or transdermal estradiol on inflammation and coagulation markers. [2008.11]

Transdermal estradiol reduces F2alpha-isoprostane levels in postmenopausal women. [2008.07]

Low-dose estradiol spray to treat vasomotor symptoms: a randomized controlled trial. [2008.06]

A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women. [2008.05]

The effect of ultralow-dose transdermal estradiol on sexual function in postmenopausal women. [2008.03]

Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial. [2008.01.11]

Endogenous estrogen levels and the effects of ultra-low-dose transdermal estradiol therapy on bone turnover and BMD in postmenopausal women. [2007.11]

Lowest Effective Transdermal 17{beta}-Estradiol Dose for Relief of Hot Flushes in Postmenopausal Women: A Randomized Controlled Trial. [2007.10]

One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women. [2007.06.20]

A clinical trial of 3 doses of transdermal 17beta-estradiol for preventing postmenopausal bone loss: a preliminary study. [2007.05]

Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women. [2007.05]

Simultaneous estradiol and levonorgestrel transdermal delivery from a 7-day patch: in vitro and in vivo drug deliveries of three formulations. [2007.04]

Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial. [2007.03]

Exogenous oestradiol and progesterone administration does not cause oedema in healthy young women. [2007.03]

Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women. [2007.01.11]

Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women. [2006.12]

Randomized comparison of lower and standard dosages of transdermal estradiol on serum estradiol levels and vaginal maturation index. [2006.09]

Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life. [2006.07]

Evidence for early initiation of growth hormone and transdermal estradiol therapies in girls with Turner syndrome. [2006.07]

Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms. [2006.03]

Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years. [2006.01]

The effect of ultralow-dose transdermal estradiol on urinary incontinence in postmenopausal women. [2005.11]

Bleeding patterns during continuous estradiol with different sequential progestogens therapy. [2005.09]

Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive. [2005.09]

Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial. [2005.06]

Effects of oral and transdermal estradiol administration on levels of sex hormone-binding globulin in postmenopausal women with and without a history of intrahepatic cholestasis of pregnancy. [2005.06]

Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study. [2005.05]

Lipids and clotting factors during low dose transdermal estradiol/norethisterone use. [2005.04.11]

Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol. [2005.04]

A randomized placebo-controlled trial of short-term graded transdermal estradiol in healthy gonadotropin-releasing hormone agonist-suppressed pre- and postmenopausal women: effects on serum markers of bone turnover, insulin-like growth factor-I, and osteoclastogenic mediators. [2005.04]

Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp. [2005.03]

Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis. [2005.02.14]

Comparison of the efficacy and tolerability of a new once-a-week matricial estradiol transdermal system (Estrapatch 40 and Estrapatch 60) with a twice week system. [2005.02]

Transdermal estradiol does not impair hemostatic biomarkers in postmenopausal women. [2005.01.10]

Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol. [2005.01]

Levels of serum C-reactive protein during oral and transdermal estradiol in postmenopausal women with and without a history of intrahepatic cholestasis of pregnancy. [2005.01]

Well-designed clinical trials possibly related to Estraderm (Estradiol Transdermal)

Testosterone replacement therapy in older male subjective memory complainers: double-blind randomized crossover placebo-controlled clinical trial of physiological assessment and safety. [2015]

Vasomotor hot flashes and heart rate variability: a placebo-controlled trial of postmenopausal hormone therapy. [2011.09.19]

Acute testosterone deprivation reduces insulin sensitivity in men. [2011.07.29]

A randomized trial of microdose leuprolide acetate protocol versus luteal phase ganirelix protocol in predicted poor responders. [2011.06.30]

Hormonal replacement therapy does not affect self-estimated pain or experimental pain responses in post-menopausal women suffering from fibromyalgia: a double-blind, randomized, placebo-controlled trial. [2011.03]

Transdermal estrogen therapy effects on fibrinogen levels in women with a past history of venous thromboembolism: a pilot study. [2011]

Beneficial influence of postmenopausal estrogen therapy on serum adhesion molecules is independent of the route and dose of administration. [2011]

Physiological versus standard sex steroid replacement in young women with premature ovarian failure: effects on bone mass acquisition and turnover. [2010.12]

Effects of estrogen and testosterone on resting energy expenditure in older men. [2010.12]

Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial. [2010.11.16]

Endometrial effect of progesterone delivered by vaginal rings in estrogen-treated postmenopausal women. [2010.10]

Hot flushes and biochemical markers for cardiovascular disease: a randomized trial on hormone therapy. [2010.10]

Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy. [2010.07]

Effectiveness of hormone therapy for treating dry eye syndrome in postmenopausal women: a randomized trial. [2010.06]

Age in men does not determine gonadotropin-releasing hormone's dose-dependent stimulation of luteinizing hormone secretion under an exogenous testosterone clamp. [2010.06]

Effect of dienogest on estrogen-induced nitric oxide production in human umbilical vein endothelial cells and endothelium-dependent vasodilatation in postmenopausal women. [2010.05]

The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women. [2010.05]

Testosterone treatment of HSDD in naturally menopausal women: the ADORE study. [2010.04]

Hormone therapy in Brazilian postmenopausal women with chronic hepatitis C: a pilot study. [2010.04]

Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study. [2010.03]

Effects of exogenous testosterone supplementation in gonadotrophin stimulated cycles. [2010.03]

Neuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal women. [2010.02]

Effect of non-oral estrogen on risk markers for metabolic syndrome in early surgically menopausal women. [2010.02]

Sexual function in first-time contraceptive ring and contraceptive patch users. [2010.01]

[Combined hormonal contraception in cycles artificially extended]. [2010.01]

Is placebo as effective as estrogen regimens on vasomotor symptoms in women with surgical menopause? [2010]

Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy. [2010]

Age in men does not determine gonadotropin-releasing hormone's dose-dependent stimulation of luteinizing hormone secretion under an exogenous testosterone clamp. [2010]

Neuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal women. [2010]

Effect of hot flushes on vascular function: a randomized controlled trial. [2009.10]

Growth hormone and sex steroid effects on serum glucose, insulin, and lipid concentrations in healthy older women and men. [2009.10]

Influence of transdermal rotigotine on ovulation suppression by a combined oral contraceptive. [2009.09]

Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). [2009.09]

Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women. [2009.09]

Effects of estrogen replacement therapy on estrogen receptor expression and immunoregulatory cytokine secretion in surgically induced menopausal women. [2009.07]

Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. [2009.05]

Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo. [2009.05]

Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction. [2009.04]

Do different delivery systems of hormone therapy have different effects on psychological symptoms in surgically menopausal women? A randomized controlled trial. [2009.02.20]

Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial. [2009.02]

Improved bleeding profile and tolerability of tibolone versus transdermal E(2)/NETA treatment in postmenopausal women with female sexual dysfunction. [2009.01.28]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017